4.6 Review

Production of tropane alkaloids by biotransformation using recombinant Escherichia coli whole cells

Journal

BIOCHEMICAL ENGINEERING JOURNAL
Volume 125, Issue -, Pages 180-189

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bej.2017.06.013

Keywords

Hyoscyamine; 6 beta-hydroxyhyoscyamine; Scopolamine; Hyoscyamine-6 beta-hydroxylase; Biotransformation; Escherichia coli whole cells

Funding

  1. Universidad de Buenos Aires
  2. Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (CONICET)
  3. Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (ANPCyT) [PIP 0156, PICT 2125, UBACyT 181]

Ask authors/readers for more resources

Tropane alkaloids, such as hyoscyamine, 6 beta-hydroxyhyoscyamine and scopolamine, are secondary metabolites that were traditionally applied in medicine due to their anticholinergic activity. Hyoscyamine is converted into 6 beta-hydroxyhyoscyamine and scopolamine by Hyoscyamine-6 beta-hydroxylase (H6H). Nowadays, these bioactive compounds are obtained from natural producer plants due to the cost and complexity of their chemical synthesis. In the present work we explored the development of an alternative strategy for the production of the most valuable alkaloids, 6 beta-hydroxyhyoscyamine and scopolamine, using Escherichia coli harboring the H6H enzyme as biocatalysts. In addition, the protein extracts of the induced bacteria were assayed for the transformation of hyoscyamine into the more valuable alkaloids. For this purpose the h6hcDNA, previously amplified from Brugmansia candida total RNA preparations, was inserted in frame to the trx tag into the pET32a(+) vector. E. coli Origami strains were used as host for the expression. The strategy allowed us to produce enough quantities of a soluble and functional enzyme. Protein extracts and whole cells of the induced bacteria were able to transform hyoscyamine into the valuable products. In addition, we found that except from 2-oxoglutarate, no supplementation of the reaction mixture with the cofactors and co-substrates was needed. The process developed in this work is attractive since it could become an alternative to the traditional isolation of 6 beta-hydroxyhyoscyamine and scopolamine. (C) 2017 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available